Strawberry Fields REIT, Inc. (STRW) Stock Analysis

Company Overview

Strawberry Fields REIT, Inc. operates as a self-administered real estate investment trust focused on the ownership, acquisition, development, and leasing of skilled nursing facilities alongside other healthcare-related properties. The company functions within the broader Real Estate sector and specifically within the REIT - Healthcare Facilities industry, positioning it to benefit from the stable demand for long-term care services. Its operational scale is defined by a market capitalization of $665.06M and a trailing twelve-month revenue of $155.00M, supported by a lean workforce of 9 employees. These valuation and revenue figures indicate that the company manages a substantial portfolio of 143 healthcare facilities containing an aggregate of 15,600+ beds, suggesting a significant physical footprint relative to its small administrative team.

Financial Health

The company generated $155.00M in revenue over the trailing twelve months, resulting in a net income of $7.58M and an EBITDA of $130.53M. The substantial gap between the $155.00M revenue and the $7.58M net income reveals a cost structure where operating expenses consume a significant portion of top-line earnings, leaving a profit margin of 4.9%. The firm reported a free cash flow of $74.17M, which indicates strong financial flexibility to cover capital expenditures or debt obligations without relying on external financing. Margin analysis shows a gross margin of 89.8%, reflecting the asset-light nature of REIT operations before overheads, while an operating margin of 52.4% demonstrates efficient management of internal costs before interest and taxes. Despite a robust operating margin, the profit margin compresses to 4.9%, highlighting the impact of interest expenses or other non-operating costs on the bottom line. On the balance sheet, the company holds $31.81M in cash against total debt of $791.35M, creating a debt-to-equity ratio of 1566.28% that signifies a highly leveraged capital structure rather than a conservative one. Liquidity is constrained by a current ratio of 0.43, which indicates that the company's current assets are insufficient to cover its current liabilities without generating additional cash flow or selling assets. Return metrics show a return on equity of 49.7% and a return on assets of 6.3%, revealing that while the equity base is utilized very effectively, the overall asset efficiency is moderate when considering the high level of leverage.

Valuation Assessment

The stock trades with a trailing P/E ratio of 19.85 and a forward P/E of 10.63, implying that the market expects a significant increase in earnings growth in the coming periods to justify the lower forward multiple. The price-to-book ratio stands at 13.04, indicating that the market values the company at a substantial premium over its net asset value, likely reflecting the quality of its healthcare portfolio or growth expectations. Alternative valuation metrics include a price-to-sales ratio of 4.29 and an EV/EBITDA of 7.33, suggesting that investors are willing to pay a high multiple relative to sales but a more moderate multiple relative to cash earnings. The 52-week price range spans from a low of $8.70 to a high of $14.00, providing a context for current trading levels relative to recent volatility. The beta value of 0.18 suggests that the stock exhibits very low price volatility relative to the broader market, moving significantly less than the overall market index.

Growth & Income

Revenue growth for the trailing twelve months was 31.5%, while earnings growth was -10.1%, indicating that earnings are currently growing slower than revenue, likely due to one-time costs or leverage effects impacting the bottom line. As a dividend payer, the company offers a dividend yield of 5.2% with a payout ratio of 100.0%, meaning the entire net income is distributed to shareholders rather than retained for reinvestment. This 100.0% payout ratio is not sustainable in the traditional sense of retaining earnings for growth, as the company distributes all profits, relying instead on its high free cash flow and asset appreciation to maintain the dividend. The overall growth and income profile is characterized by rapid top-line expansion and a high-yield income stream that fully distributes current earnings, balancing capital appreciation potential with immediate income generation.